Alexandria Real Estate Equities, Inc. (ARE)
Alexandria Real Estate: Oversupply Torpedoes Guidance
On our previous coverage, we highlighted the big problems that Alexandria REIT faced. The miss this morning validates the thesis. There is a secular trend in place now and we are still not interested in buying.
Alexandria's Q3 AFFO & Revenues Miss Estimates, '25 View Narrowed
ARE's Q3 miss, lower occupancy and rising interest costs drag results, prompting a 2025 FFO guidance cut.
Alexandria Real Estate Equities (ARE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Alexandria Real Estate Equities (ARE) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alexandria Real Estate Equities (ARE) Lags Q3 FFO and Revenue Estimates
Alexandria Real Estate Equities (ARE) came out with quarterly funds from operations (FFO) of $2.22 per share, missing the Zacks Consensus Estimate of $2.31 per share. This compares to FFO of $2.37 per share a year ago.
More Rate Cuts Are Coming: Grab 6% High-Yield S&P 500 Stocks Now
Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.
Alexandria to Post Q3 Earnings: What to Expect From the Stock?
ARE's Q3 results may show lower revenues and FFO as occupancy pressures weigh on performance.
Alexandria Real Estate Equities Is A Great Prospect Despite Real Challenges
Alexandria Real Estate Equities remains a "Strong Buy" due to its attractive valuation and strategic position in the life sciences REIT sector. ARE is actively recycling its portfolio, selling non-revenue assets and reinvesting proceeds to reduce debt and fund new developments, despite recent revenue and profit declines. The company's megacampus strategy and focus on life sciences position it for long-term growth, even as sector vacancy rates and industry headwinds persist.
The Real Catalyst Behind Alexandria Real Estate
Alexandria Real Estate generated an 11% return in Q3. It may be starting to turn around its performance. With a 6.3% yield, a 57% payout ratio, and solid AFFO, ARE's dividend security stands out among healthcare REITs despite sector headwinds. I analyzed a catalyst that investors sometimes forget about in ARE: the potential of Big Pharma and Big Biotech.
Two Retirement Bargains With Upside Potential
As retirement nears, portfolio focus should shift from growth to downside protection and stable income. For most of us it is crucial to limit drawdown risk, maintain income streams, and preserve inflation-adjusted value. Here ultra-conservative assets may not suit well.
Alexandria Stock Gains 19.3% in 3 Months: Will the Trend Continue?
ARE stock's 19.3% rise in three months is fueled by demand for its Class A/A+ properties, strong occupancy and solid financial footing.
What I Wish I Knew Before Becoming A REIT Investor
I have made many mistakes in my REIT investing career. Some of which have cost me dearly. Learn from me to improve your future investment results.
My Top 3 AI Stocks In Real Estate
Artificial intelligence is set to revolutionize the world we live in. I think that it is a major headwind for most stocks. But it could turn into a huge tailwind for certain real assets.
